COMBITIDE 250 INHALER

Description

COMBITIDE 250 Inhaler combines Budesonide (250 mcg), an inhaled corticosteroid (ICS), and Formoterol Fumarate, a long-acting beta-2 agonist (LABA), in a metered-dose inhaler designed for the treatment and maintenance of asthma and chronic obstructive pulmonary disease (COPD).

Budesonide reduces inflammation and swelling in the airways, while formoterol relaxes bronchial muscles to provide prolonged bronchodilation. This dual action helps control and prevent symptoms such as wheezing, shortness of breath, and coughing, improving lung function and quality of life.

Key Benefits:

• Provides anti-inflammatory and bronchodilator effects

• Helps prevent asthma attacks and COPD exacerbations

• Metered-dose inhaler for precise and convenient delivery

• Improves breathing and lung capacity

Indications:

• Maintenance treatment of asthma

• Management of chronic obstructive pulmonary disease (COPD)

Dosage:
As prescribed, typically 1-2 puffs twice daily.

Precautions:
Not for relief of acute bronchospasm. Use under medical supervision. Possible side effects include oral thrush and tremors; rinse mouth after use.